Copyright
©2010 Baishideng.
World J Gastroenterol. May 21, 2010; 16(19): 2371-2377
Published online May 21, 2010. doi: 10.3748/wjg.v16.i19.2371
Published online May 21, 2010. doi: 10.3748/wjg.v16.i19.2371
n | HepG2 | P | Hep3B | P | |||
Control group | Experiment group | Control group | Experiment group | ||||
HSP70 | 3 | 74.2 ± 3.1 | 99.8 ± 5.2 | < 0.01 | 70.2 ± 5.1 | 99.9 ± 3.8 | < 0.01 |
HLA-I | 3 | 53.3 ± 2.5 | 79.6 ± 6.1 | < 0.01 | 40.6 ± 2.7 | 86.7 ± 3.6 | < 0.01 |
NY-ESO-1 | 3 | 38.2 ± 4.2 | 58.2 ± 4.3 | < 0.01 | 32.1 ± 4.6 | 70.3 ± 2.9 | < 0.01 |
Subject | n | HepG2 con | HepG2 exp | P | Hep3B con | Hep3B exp | P |
Exo No | 3 | 3.56 × 108± 2.6 × 102 | 4.53 × 109± 3.7 × 102 | 0.010 | 3.12 × 108± 6.2 × 102 | 4.13 × 109± 3.7 × 102 | 0.021 |
Exo Pro | 3 | 0.92 ± 0.13 mg | 1.31 ± 0.16 mg | 0.012 | 0.89 ± 0.10 mg | 1.52 ± 0.16 mg | 0.011 |
- Citation: Xiao WH, Sanren GW, Zhu JH, Li QW, Kang HR, Wang RL, Song LP, Ye M. Effect of 5-Aza-2’-deoxycytidine on immune-associated proteins in exosomes from hepatoma. World J Gastroenterol 2010; 16(19): 2371-2377
- URL: https://www.wjgnet.com/1007-9327/full/v16/i19/2371.htm
- DOI: https://dx.doi.org/10.3748/wjg.v16.i19.2371